Premier Biomedical, Inc. (BIEI)
- Previous Close
0.0013 - Open
0.0012 - Bid --
- Ask --
- Day's Range
0.0012 - 0.0013 - 52 Week Range
0.0005 - 0.0017 - Volume
48,032 - Avg. Volume
1,692,136 - Market Cap (intraday)
1.6M - Beta (5Y Monthly) -4.16
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
www.premierbiomedical.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: BIEI
Performance Overview: BIEI
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIEI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIEI
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
112.03
Enterprise Value/EBITDA
76.52
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-153.58%
Return on Equity (ttm)
--
Revenue (ttm)
14.28k
Net Income Avi to Common (ttm)
-374.47k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
71.2k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-310.46k
Company Insights: BIEI
BIEI does not have Company Insights